Proposal of new imaging criteria for evaluating the response of liver metastases to systemic treatments in digestive neuroendocrine tumors (NET) as an alternative to RECIST 1.1
dc.contributor.author | de Mestier, L | |
dc.contributor.author | Dromain, C | |
dc.contributor.author | Lamarca, Angela | |
dc.contributor.author | La Salvia, A | |
dc.contributor.author | Op de Beeck, B | |
dc.contributor.author | Fehrenbach, U | |
dc.contributor.author | Pusceddu, S | |
dc.contributor.author | Colao, A | |
dc.contributor.author | Borbath, B | |
dc.contributor.author | de Haas, R | |
dc.contributor.author | Ruszniewski, P | |
dc.contributor.author | Vullierme, MP | |
dc.date.accessioned | 2020-06-15T12:57:36Z | |
dc.date.available | 2020-06-15T12:57:36Z | |
dc.date.issued | 2020 | en |
dc.identifier.citation | de Mestier L, Dromain C, Lamarca A, La Salvia A, Op de Beeck B, Fehrenbach U, et al. Proposal of new imaging criteria for evaluating the response of liver metastases to systemic treatments in digestive neuroendocrine tumors (NET) as an alternative to RECIST 1.1. Neuroendocrinology. 2020;110:163- | en |
dc.identifier.uri | http://hdl.handle.net/10541/622957 | |
dc.language.iso | en | en |
dc.title | Proposal of new imaging criteria for evaluating the response of liver metastases to systemic treatments in digestive neuroendocrine tumors (NET) as an alternative to RECIST 1.1 | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Beaujon Hospital, Clichy, France | en |
dc.identifier.journal | Neuroendocrinology | en |
dc.description.note | en] |